Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Sosa-Eroza

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Archives of Medical Research|October 8, 2023
Long-term Discontinuation of Dopamine Agonist Treatment in Patients with Prolactinomas RevisitedErnesto Sosa-Eroza, Etual Espinosa-Cárdenas
Endocrine|June 28, 2018
Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LARErnesto Sosa-Eroza, Etual Espinosa, Claudia Ramírez-Rentería, et al.
The Journal of Clinical Endocrinology and Metabolism|July 31, 2018
Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at DiagnosisAna Laura Espinosa de Los Monteros, Ernesto Sosa-Eroza, Baldomero Gonzalez, et al.
Archives of Medical Research|September 25, 2023
Non-Invasive Biochemical Testing of ACTH-dependent Cushing's Disease: Do We Still Need Petrosal Sinus Sampling?Etual Espinosa-Cardenas, Manuel Garcia-Saenz, Ana Laura Espinosa de Los Monteros-Sanchez, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2017
LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASEAna Laura Espinosa-de-Los-Monteros, Ernesto Sosa-Eroza, Etual Espinosa, et al.
Endocrine|June 18, 2020
High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?Etual Espinosa-Cárdenas, Miriam Sánchez-García, Claudia Ramírez-Rentería, et al.
Endocrine|January 21, 2021
Response to Letter to the Editor: "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?"Etual Espinosa-Cárdenas, Miriam Sánchez-García, Claudia Ramírez-Rentería, et al.
Clinical Endocrinology|May 12, 2026
Flushing: Neuroendocrine Mechanisms and a Structured Diagnostic ApproachManuel Ramón García-Sáenz, Ernesto Sosa-Eroza, Aldo Ferreira-Hermosillo, et al.
Archives of Medical Research|April 28, 2026
Role of Tumor Volume and Prolactin Ratios in Differentiating Prolactinomas and Predicting Response to CabergolineManuel Ramón García-Sáenz, Jesús Iván Castro-Murillo, Moisés Mercado, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|October 20, 2004
[Coexistent diseases in allergic asthmatic patients. A study of 100 cases]Nora Hilda Segura Méndez, Miriam Parra Román, Fabiola Dinorah Espinosa Leal, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Archives of Medical Research|October 8, 2023
Long-term Discontinuation of Dopamine Agonist Treatment in Patients with Prolactinomas RevisitedErnesto Sosa-Eroza, Etual Espinosa-Cárdenas
Endocrine|June 28, 2018
Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LARErnesto Sosa-Eroza, Etual Espinosa, Claudia Ramírez-Rentería, et al.
The Journal of Clinical Endocrinology and Metabolism|July 31, 2018
Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at DiagnosisAna Laura Espinosa de Los Monteros, Ernesto Sosa-Eroza, Baldomero Gonzalez, et al.
Archives of Medical Research|September 25, 2023
Non-Invasive Biochemical Testing of ACTH-dependent Cushing's Disease: Do We Still Need Petrosal Sinus Sampling?Etual Espinosa-Cardenas, Manuel Garcia-Saenz, Ana Laura Espinosa de Los Monteros-Sanchez, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2017
LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASEAna Laura Espinosa-de-Los-Monteros, Ernesto Sosa-Eroza, Etual Espinosa, et al.
Endocrine|June 18, 2020
High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?Etual Espinosa-Cárdenas, Miriam Sánchez-García, Claudia Ramírez-Rentería, et al.
Endocrine|January 21, 2021
Response to Letter to the Editor: "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?"Etual Espinosa-Cárdenas, Miriam Sánchez-García, Claudia Ramírez-Rentería, et al.
Clinical Endocrinology|May 12, 2026
Flushing: Neuroendocrine Mechanisms and a Structured Diagnostic ApproachManuel Ramón García-Sáenz, Ernesto Sosa-Eroza, Aldo Ferreira-Hermosillo, et al.
Archives of Medical Research|April 28, 2026
Role of Tumor Volume and Prolactin Ratios in Differentiating Prolactinomas and Predicting Response to CabergolineManuel Ramón García-Sáenz, Jesús Iván Castro-Murillo, Moisés Mercado, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|October 20, 2004
[Coexistent diseases in allergic asthmatic patients. A study of 100 cases]Nora Hilda Segura Méndez, Miriam Parra Román, Fabiola Dinorah Espinosa Leal, et al.
Pageof 3